home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Webinar On Medical Device Laws and Regulations in Asia: China, Hong Kong, Japan and Korea

  November 20, 2014  

Compliance Trainings, Canada

This webinar is intended to help you get familiar with medical device laws and regulations in Asian countries: China, Hong Kong, Japan, and Korea.

The medical devices are currently one of the fastest growing industries. The current knowledge and accurate understanding and adequate interpretation of global medical device laws, regulations and regulatory requirements have become increasingly important in our competitive global market. Global regulations of medical devices are rapidly evolving, which necessitates the integration of regulatory schemes available and applicable in various regions of the world to best develop a practical, actionable and sustainable regulatory plan and strategy. For many reasons, Asian medical device markets are highly attractive. Thus, it is imperative we get familiar with currently applicable and relevant laws and regulations governing medical devices, further streamlining the regulatory process.

In this webinar, the speaker will discuss the updated differences in regulatory frameworks (regulatory requirements and compliance) in Asia, intending to help you understand and accurately interpret applicable laws and regulations governing medical devices in China, Hong Kong, Japan and Korea. This webinar will help you expedite the registration process for your devices in these Asian countries.

Speaker will present laws and regulations governing medical devices in China, Hong Kong, Japan and Korea. It is designed to help medical device industry implement practical, actionable and sustainable strategy for device registration in these countries and further to streamline their business planning and registration process in Asian countries.

Areas Covered in the Session :

Updated medical device laws and regulations in China, Hong Kong, Japan and Korea.

Definitions, Device classification and rules

Regulatory framework for medical devices in China, Hong Kong, Japan and Korea.

Regulatory requirements for medical devices including in vitro diagnostic devices in China, Hong Kong, Japan and Korea.

How to identify and address the regulatory requirements

How to establish and maintain systematic methods to meet the regulatory requirements.

How to streamline the regulatory process.

Suggestions for best practices in a PASS-IT manner

Interactive Q&A session

Who Will Benefit:

Regulatory Affairs Managers, Directors and VPs

Clinical Affairs Managers, Directors and VPs

Quality Managers, Directors and VPs

Quality Managers, Directors and VPs

Compliance Managers and Directors

Sales and Marketing Managers, Directors, and VPs

Complaint Handling and Risk Management Managers and Directors

Site Managers, Directors, and Consultants

Senior and Executive Management

Compliance Officers and Legal Counsel

Business Development Managers, Directors, and VPs

Price Tags:


Single Live : For One Participant

$ 249

Corporate Live : For Max. 10 Participants

$ 899


Single REC : For One Participant - Unlimited Access for 6 Months

$ 299

For more information and enquiries contact us at

Compliance Trainings

5939 Candle brook Ct, Mississauga, ON L5V 2V5, Canada 
Customer Support: 416-915-4458 
Email: support@compliancetrainings.com

Organized by: Compliance Trainings
Invited Speakers:

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor (www.RegulatoryDoctor.com). Dr. Lim frequently presents global regulatory and quality compliance topics in various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author. Dr. Lim leads and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.

Deadline for Abstracts: 2014-11-15



E-mail: suzzane.d@compliancetrainings.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.